Filter by
Our projects (118)
RSSShowing results 1 to 20
Understanding mpox virus infectionsThe MOVIE-TRACE project is clarifying two key aspects of mpox infections: the speed at which the virus is cleared from the body and its infectiousness.
Field-testing moxidectin for river blindness controlThe EMINENCE project is exploring whether a newly developed drug, moxidectin, could accelerate the elimination of onchocerciasis (river...
Advancing monoclonal antibodies to treat HIV in infantsThe ENABLE project is assessing whether broadly neutralising antibodies could make the HIV virus undetectable in young infants.
Our overall objective is to integrate our consortium’s individual skills, capacity and innovations into advanced, low-cost and deployable digital dashboards and diagnostics to understand how...
Standardised tracking of malaria and tuberculosis drug resistance The PANGenS project will introduce standardised approaches for identifying malaria and TB genetic variants associated with...
Access to vaccines against neglected tropical diseases (NTDs) is limited in sub-Saharan Africa (SSA), where NTD burdens are high, while vaccine trials often are performed in Western...
The current Mpox outbreak affecting the Democratic Republic of the Congo, ongoing since 2023, has resulted in more than 19,000 causes and over 1,000 deaths, with women accounting for more...
Extending ivermectin use to young childrenThe IVM-KIDS project is developing a child-friendly formulation of ivermectin to ensure young children can benefit from this key drug for parasite...
Repurposing fusidic acid for onchocerciasis controlThe FAME project is assessing whether a repurposed antibiotic could improve control of onchocerciasis (river blindness).
TB prevention in people living with diabetesThe EDCTP2-funded PROTID project has received additional Global Health EDCTP3 funding, enabling it to complete its trial of preventive TB...
Tackling severe malaria in remote locationsThe SEMA ReACT study will determine whether children with severe malaria can be treated entirely in the community, when transportation to health...
Accelerating young people’s access to antiretroviralsThe CHAPAS-5 project is establishing a flexible clinical trial platform that will accelerate the evaluation of antiretroviral treatments...
Diagnosing skin conditions with AIThe SkincAIr project is developing an easy-to-use AI-based tool to support the diagnosis of skin conditions caused by neglected tropical diseases.
Supporting the next generation of African scientistsThe SOFAR project is establishing a training programme to advance the careers of promising students and early-career researchers in...
Coordinated strengthening of ethics review and regulatory capacity The SCALE-IT project is using a coordinated approach to strengthen ethics review and regulatory capacity across multiple...
Strengthening research capacity in Portuguese-speaking countriesThe CT-Luso project is developing ethical review and regulatory capacity specifically in Portuguese-speaking countries in sub...
Enhancing treatment of parasitic worm infectionsThe eWHORM project is using an innovative trial design to assess the efficacy of a promising new therapeutic, oxfendazole, against multiple...
Once-weekly pills for HIV controlThe POA project is evaluating a radically simplified HIV treatment regimen that could make it much easier for people living with HIV to control viral...
New options for drug-resistant tuberculosisThe EX-DR TB project is aiming to preserve the potency of a key TB drug, bedaquiline, and advance the development of potential successors.
Rapid protection against Ebola virusThe EBO-PEP project is evaluating whether monoclonal antibodies can protect close contacts of people with Ebola virus infections.